Ellen O'Connor Vos, Director at OptimizeRx Corp (OPRX), bought 600 shares at $9.62 ($6K) on 2019-11-13, disclosed to the SEC on 2019-11-14.
Open-market purchase of $6k OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MODD | BUY | 2021-11-01 | $300K | — | Filing → |
| OPRX | BUY | 2020-04-01 | $9K | — | Filing → |
| OPRX | BUY | 2018-06-27 | $19K | — | Filing → |